We are live on
!
Find out more
ProShare Advisors Portfolio holdings
AUM
$67.5B
1-Year Est. Return
28.09%
This Quarter
Est. Return
+9.54%
1 Year Est. Return
+28.09%
3 Year Est. Return
+88.43%
5 Year Est. Return
+118.21%
10 Year Est. Return
+464.8%
AUM
$21.6B
AUM Growth
+$3.73B
(+21%)
Cap. Flow
+$2.14B
Cap. Flow
% of AUM
9.89%
Top 10 Holdings %
Top 10 Hldgs %
20.71%
Holding
1,837
New
181
Increased
1,318
Reduced
286
Closed
50
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$34M |
| 2 |
ExxonMobil
XOM
|
+$33.1M |
| 3 |
Johnson & Johnson
JNJ
|
+$32.7M |
| 4 |
3M
MMM
|
+$32.4M |
| 5 |
McDonald's
MCD
|
+$32.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$70M |
| 2 |
W.R. Berkley
WRB
|
+$12.8M |
| 3 |
ISCA
International Speedway Corp
ISCA
|
+$11.2M |
| 4 |
CTWS
Connecticut Water Service Inc
CTWS
|
+$11.2M |
| 5 |
Gen Digital
GEN
|
+$10.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.41% |
| 2 | Financials | 12.4% |
| 3 | Industrials | 11.69% |
| 4 | Healthcare | 11.57% |
| 5 | Consumer Staples | 11.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
876
Adaptive Biotechnologies
ADPT
$3.56B
| $804K | ﹤0.01% |
+26,888
| New | +$772K |
|
877
IPG Photonics
IPGP
$3.89B
| $804K | ﹤0.01% |
5,546
+1,264
| +30% | +$176K |
|
|
TWO
878
Two Harbors Investment
TWO
$1.27B
| $803K | ﹤0.01% |
13,732
-539
| -4% | -$30.5K |
|
|
ARNA
879
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $803K | ﹤0.01% |
17,681
-1,496
| -8% | -$70.7K |
|
880
Wintrust Financial
WTFC
$10.7B
| $801K | ﹤0.01% |
11,303
+391
| +4% | +$26.1K |
|
|
ZGNX
881
DELISTED
Zogenix, Inc.
ZGNX
| $801K | ﹤0.01% |
15,362
-1,011
| -6% | -$46.3K |
|
882
Ligand Pharmaceuticals
LGND
$6.02B
| $793K | ﹤0.01% |
12,194
-1,736
| -12% | -$116K |
|
883
Avient
AVNT
$3.45B
| $790K | ﹤0.01% |
21,465
+1,867
| +10% | +$61K |
|
884
Louisiana-Pacific
LPX
$5.2B
| $788K | ﹤0.01% |
26,547
+2,539
| +11% | +$71.7K |
|
885
CRISPR Therapeutics
CRSP
$4.58B
| $783K | ﹤0.01% |
12,856
-1,941
| -13% | -$106K |
|
|
WPX
886
DELISTED
WPX Energy, Inc.
WPX
| $781K | ﹤0.01% |
56,812
+1,615
| +3% | +$17.2K |
|
|
EPZM
887
DELISTED
Epizyme, Inc
EPZM
| $779K | ﹤0.01% |
31,663
-1,824
| -5% | -$27.1K |
|
|
CIM
888
Chimera Investment
CIM
$1.05B
| $775K | ﹤0.01% |
12,564
-498
| -4% | -$30.4K |
|
889
Outfront Media
OUT
$5.64B
| $775K | ﹤0.01% |
29,370
-1,115
| -4% | -$28.7K |
|
890
Agios Pharmaceuticals
AGIO
$2.16B
| $774K | ﹤0.01% |
16,209
-910
| -5% | -$34.4K |
|
891
Alkermes
ALKS
$8.82B
| $772K | ﹤0.01% |
37,862
-8,365
| -18% | -$166K |
|
|
UMPQ
892
DELISTED
Umpqua Holdings Corp
UMPQ
| $772K | ﹤0.01% |
43,643
+1,219
| +3% | +$20.2K |
|
|
SAFM
893
DELISTED
Sanderson Farms Inc
SAFM
| $771K | ﹤0.01% |
4,376
+617
| +16% | +$97.5K |
|
894
World Kinect Corp
WKC
$1.96B
| $769K | ﹤0.01% |
17,706
+1,758
| +11% | +$73.5K |
|
895
Murphy USA
MUSA
$11.3B
| $767K | ﹤0.01% |
6,558
+665
| +11% | +$71.7K |
|
896
Darling Ingredients
DAR
$9.93B
| $766K | ﹤0.01% |
27,274
+3,940
| +17% | +$87.9K |
|
897
Lennox International
LII
$18.8B
| $764K | ﹤0.01% |
3,132
+329
| +12% | +$81.6K |
|
898
Chemed
CHE
$6.78B
| $763K | ﹤0.01% |
1,738
+166
| +11% | +$69.8K |
|
899
Bank of Hawaii
BOH
$3.33B
| $759K | ﹤0.01% |
7,976
+156
| +2% | +$13.9K |
|
|
FUT
900
DELISTED
ProShares Managed Futures Strategy ETF
FUT
| $758K | ﹤0.01% |
19,311
-5,688
| -23% | -$226K |
|
Similar funds
ProShare Advisors's Q4 2019 Portfolio in Review
As of Q4 2019, ProShare Advisors held 1,837 positions worth $21.6B, up 21% from $17.9B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
ProShare Advisors deployed $2.14B of net new capital in Q4 2019, opening 181 new positions and adding to 1,318 existing holdings. Its largest new stake was Pennant Group: 484,308 shares worth $16M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Financials and Industrials.
On the sell side, the largest reduction was W.R. Berkley, an estimated $12.8M trimmed.
- ProShare Advisors's largest Q4 2019 buy was Pennant Group: 484,308 shares worth $16M.
- ProShare Advisors added most to Alphabet (Google) Class A in Q4 2019, an estimated $34M increase.
- ProShare Advisors's biggest Q4 2019 reduction was W.R. Berkley, cutting an estimated $12.8M.
- ProShare Advisors fully exited Celgene Corp in Q4 2019, selling an estimated $70M.
- ProShare Advisors's ten largest holdings make up 21% of its $21.6B portfolio in Q4 2019.
- ProShare Advisors opened 181 new positions and closed 50 in Q4 2019.
- ProShare Advisors's portfolio value rose 21% quarter-over-quarter to $21.6B.
Based on ProShare Advisors's 13F filing for Q4 2019, filed 12 Feb 2020.